Clinical Trials for Metastatic Castration-resistant Prostate Carcinoma

Find clinical trials for metastatic castration-resistant prostate carcinoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

NCT ID: NCT05113537

This clinical trial is studying a new treatment approach for men with advanced prostate cancer that has spread to other parts of the body and is no longer responding to standard hormone therapy. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

NCT ID: NCT06705686

This clinical trial is studying a new drug called (R)-9bMS to see if it is safe for patients with metastatic castration-resistant prostate cancer (CRPC), a type of prostate cancer that continues to...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Madison, Wisconsin, United States

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

NCT ID: NCT06099093

This clinical trial is exploring how well a special imaging test called 18F-DCFPyL PSMA PET can show the spread of prostate cancer in patients who have metastatic castration-resistant prostate canc...

Recruiting

Phase: PHASE4 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions